Courier Capital LLC Trims Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Courier Capital LLC decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,725 shares of the company’s stock after selling 286 shares during the period. Courier Capital LLC’s holdings in GE HealthCare Technologies were worth $368,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Wynn Capital LLC grew its position in shares of GE HealthCare Technologies by 4.1% during the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after buying an additional 122 shares in the last quarter. Byrne Asset Management LLC boosted its position in GE HealthCare Technologies by 0.8% during the first quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock valued at $1,493,000 after purchasing an additional 126 shares in the last quarter. WASHINGTON TRUST Co boosted its position in GE HealthCare Technologies by 7.7% during the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock valued at $168,000 after purchasing an additional 133 shares in the last quarter. Fiduciary Trust Co boosted its position in GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after purchasing an additional 133 shares in the last quarter. Finally, Quent Capital LLC raised its stake in GE HealthCare Technologies by 21.3% in the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock valued at $71,000 after buying an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at $5,296,510. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Mizuho reduced their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Bank of America cut their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective on the stock. Finally, The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $95.00.

GE HealthCare Technologies Trading Down 0.5 %

Shares of GEHC stock traded down $0.44 during mid-day trading on Thursday, hitting $84.04. 336,343 shares of the company’s stock were exchanged, compared to its average volume of 3,021,377. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The stock has a 50-day simple moving average of $80.45 and a two-hundred day simple moving average of $83.31. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. The stock has a market cap of $38.36 billion, a price-to-earnings ratio of 24.63, a PEG ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same quarter last year, the firm earned $0.92 earnings per share. The business’s revenue was up .5% on a year-over-year basis. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.